Quan DH, Kwong AJ, Hansbro PM, Britton WJ
Under section 503A, a licensed pharmacist in a state-licensed pharmacy or federal facility, or a licensed physician who compounds, may use a bulk drug substance through one of three statutory routes
Summary: Retatrutide is not currently available in the UK or globally, as it remains an investigational medicine without marketing authorisation, accessible only through authorised clinical trials as of mid-2025
What you get when you sign up with Found is access to doctors who can evaluate your weight loss needs and prescribe medication accordingly
For additional resources on GLP-1 Receptor Agonists and how they will change the health care & life sciences and technology industries, click here to read the other articles in our series
Trends biochemical Sci